IS INCREASED SERUM INTERLEUKIN-35 LEVELS A DISEASE ACTIVITY MARKER IN DERMATOMYOSITIS AND POLYMYOSITIS?

被引：0
|
作者：
Yin, L. [1 ]
Wang, G. [2 ]
Ge, Y. [2 ]
机构：
[1] Peking Univ, China Japan Friendship Sch Clin Med, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Rheumatol, Beijing, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.3606
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0615
引用
收藏
页码：1114 / 1114
页数：1
相关论文
共 50 条
  • [21] Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease
    Nakatsuka, Yoshinari
    Handa, Tomohiro
    Nakashima, Ran
    Tanizawa, Kiminobu
    Kubo, Takeshi
    Murase, Yuko
    Sokai, Akihiko
    Ikezoe, Kohei
    Hosono, Yuji
    Watanabe, Kizuku
    Tokuda, Shinsaku
    Uno, Kazuko
    Yoshizawa, Akihiko
    Tsuruyama, Tatsuaki
    Uozumi, Ryuji
    Nagai, Sonoko
    Hatta, Kazuhiro
    Taguchi, Yoshio
    Mishima, Michiaki
    Chin, Kazuo
    Mimori, Tsuneyo
    Hirai, Toyohiro
    RHEUMATOLOGY, 2019, 58 (08) : 1465 - 1473
  • [22] Different expression levels of interleukin-35 in asthma phenotypes
    Li, Wei
    Gao, Ruihan
    Xin, Tong
    Gao, Peng
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [23] Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis
    Yuan, L.
    Yao, L.
    Zhao, L.
    Xia, L.
    Shen, H.
    Lu, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (03) : 428 - 432
  • [24] Different expression levels of interleukin-35 in asthma phenotypes
    Wei Li
    Ruihan Gao
    Tong Xin
    Peng Gao
    Respiratory Research, 21
  • [25] Serum Microrna-1 Can be a Predictive Marker for Disease Activity of Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease
    Sugiyama, Yumiko
    Yoshimi, Ryusuke
    Kunishita, Yosuke
    Kishimoto, Daiga
    Kirino, Yohei
    Nakajima, Hideaki
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and Polymyositis
    de Sordi, Cintia M.
    dos Reis-Neto, Edgard T.
    Keppeke, Gerson D.
    Shinjo, Samuel K.
    Sato, Emilia Inoue
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : 33 - 37
  • [27] Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide
    Espes, Daniel
    Singh, Kailash
    Sandler, Stellan
    Carlsson, Per-Ola
    DIABETES CARE, 2017, 40 (08) : 1090 - 1095
  • [28] Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease
    Sun, Min
    Xing, Haijian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [29] Evaluation of serum interleukin-35 level in children with persistent asthma
    Khoshkhui, Maryam
    Alyasin, Soheyla
    Sarvestani, Eskandar Kamali
    Amin, Reza
    Ariaee, Nazila
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2017, 35 (02): : 91 - 95
  • [30] The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis
    Liguo Yin
    Yongpeng Ge
    Hanbo Yang
    Qinglin Peng
    Xin Lu
    Yamei Zhang
    Guochun Wang
    Clinical Rheumatology, 2016, 35 : 2715 - 2721
12345